Plasma osteopontin levels in patients with Behcet's disease and psoriasis

dc.contributor.authorErturkler, Enis
dc.contributor.authorCicek, Demet
dc.contributor.authorKaman, Dilara
dc.contributor.authorOzdogan, Serhat
dc.contributor.authorDertlioglu, Selma Bakar
dc.date.accessioned2026-08-12T17:14:37Z
dc.date.issued2011
dc.departmentFırat Üniversitesi
dc.description.abstractBackground: Behcet's disease (BD) is a chronic and recurrent systemic vasculitis marked by macrophage chemotaxis. Objective: The present study aimed to examine the relationship between the osteopontin molecule and BD. Patients and Methods: The study registered 60 patients with BD, as well as 50 healthy individuals and 63 patients with psoriasis as the control group. Patients with BD in our study were divided into 2 groups, with regard to mucocutaneous involvement, as active and inactive patients. In addition, patients with BD were also divided into 3 groups with regard to vascular involvement: active, inactive, and no vascular involvement. Results: Plasma osteopontin (OPN) levels in active patients with BD, inactive patients with BD and patients with psoriasis were found statistically significantly elevated, in comparison to those in the healthy control group (p < 0.001, p = 0.008, p < 0.001, respectively). When active and inactive patients with BD were compared to the healthy control group with regard to vascular involvement, mean plasma OPN levels were found to be statistically significantly higher (p = 0.01, p < 0.001, respectively). Conclusions: We found that plasma levels of OPN were higher in patients with Behcet's and psoriasis.
dc.description.sponsorshipFUBAP, (Turkey)
dc.description.sponsorshipThis work was supported by a grant from FUBAP, 1926 (Turkey).
dc.identifier.doi10.1684/ejd.2011.1252
dc.identifier.endpage208
dc.identifier.issn1167-1122
dc.identifier.issn1952-4013
dc.identifier.issue2
dc.identifier.pmid21489910
dc.identifier.scopus2-s2.0-79960766860
dc.identifier.scopusqualityQ2
dc.identifier.startpage203
dc.identifier.urihttps://doi.org/10.1684/ejd.2011.1252
dc.identifier.urihttps://hdl.handle.net/11508/51898
dc.identifier.volume21
dc.identifier.wosWOS:000291024000011
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherJohn Libbey Eurotext Ltd
dc.relation.ispartofEuropean Journal of Dermatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectBehcet's disease
dc.subjectpsoriasis
dc.subjectosteopontin
dc.titlePlasma osteopontin levels in patients with Behcet's disease and psoriasis
dc.typeArticle

Dosyalar